Pharmaron integrated drug discovery services with milestone-based models.
Integrated Drug Discovery and Development is Pharmaron's service spanning biology, chemistry, and preclinical development for pharmaceutical partners. It is offered under risk- and milestone-based engagement models.
The service includes protein degrader expertise, supporting clients' targeted protein degradation programs within integrated discovery collaborations.
transMedChem
Drug Discovery Consulting Services
transmedchem.com
Beactica Therapeutics
Drug Discovery Partnerships
beactica.com
Adds products that compete with one of Integrated Drug Discovery and Development’s direct competitors but not with Integrated Drug Discovery and Development itself. They are shaded, and Linked Through names the direct competitor each one competes with.
Provider 
Founded —
Sells To —
Pricing Model —
Ownership —
Provider
Founded 2012
Sells To —
Pricing Model —
Ownership —
Provider
Founded 2006
Sells To Businesses
Pricing Model Pre-Revenue
Ownership Private
Linked Through Drug Discovery Consulting Services
Provider 
Founded 2012
Sells To Enterprise
Pricing Model —
Ownership Private
Linked Through Drug Discovery Partnerships
Provider 
Founded 1947
Sells To Enterprise, Small Business
Pricing Model Recurring, Transactional
Ownership Public
Linked Through Drug Discovery Partnerships
Provider 
Founded 1998
Sells To Enterprise
Pricing Model —
Ownership Public
Linked Through Drug Discovery Consulting Services
Provider 
Founded 2011
Sells To Pharmaceutical Manufacturers
Pricing Model Service Fees
Ownership Private
Linked Through Drug Discovery Consulting Services
Provider 
Founded 2009
Sells To —
Pricing Model —
Ownership —
Charles River integrated small-molecule drug discovery and development services.
Jubilant Biosys integrated small-molecule drug discovery services.
Preclinical drug development consulting service of Alacrita, covering discovery support through candidate selection.
Medicinal chemistry and drug discovery consulting service of ChemTract, led by owner James M. Balkovec.
Drug discovery consulting service of Discovery Innovations, serving biotech and pharmaceutical partners from hit identification through preclinical candidate selection.
Charles River integrated small-molecule drug discovery and development services.
Jubilant Biosys integrated small-molecule drug discovery services.
Preclinical drug development consulting service of Alacrita, covering discovery support through candidate selection.
Medicinal chemistry and drug discovery consulting service of ChemTract, led by owner James M. Balkovec.
Drug discovery consulting service of Discovery Innovations, serving biotech and pharmaceutical partners from hit identification through preclinical candidate selection.